Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by skiptoggleon Nov 26, 2019 9:23am
91 Views
Post# 30392710

RE:Condensate remains at a premium to WTI

RE:Condensate remains at a premium to WTIMaking the assumption that those increase prices remain for the next year.  Question, aren't some 50% of production sales hedged?  So we can only count on half of those oil and gas price increases to apply to future production.  It is a positive development but maybe they can use some of the increased $$ to accelerate paying down debt while maintaining status quo on the capital expenditure plan.

Don2018 wrote: Closed at $77.48 Can yesterday.

That is $8 above the price used in their guidance, which would add another $17.5 million to their cash flow.

And natural gas is about a buck above guidance, which would add yet another $17.5 million.

That is $35 million more to drill wells to increase our production. That ain't chickenfeed!


<< Previous
Bullboard Posts
Next >>